Previous 10 | Next 10 |
Inovio (NASDAQ:INO) perks up 2% premarket after receiving regulatory allowance for two clinical trials investigating heterologous boosting with INO-4800, its DNA vaccine candidate for COVID-19, through partner and trial-sponsor Advaccine Biopharmaceuticals Suzhou Co., Ltd. toge...
You can read the full article here. For further details see: Wall Street Breakfast: China Wipeout (Podcast)
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. China wipeoutSweeping crackdowns across China are continuing to send shockwaves across financial markets, with investors finding themselves in the firing l...
Nathan Howard/Getty Images News An increasing amount of districts and cities have already imposed fresh mask mandates, but a surge in Delta cases is prompting several localities to go one step farther. California will soon require state employees and all healthcare workers to provide proof of...
Kevin Frayer/Getty Images News According to a lab study, antibodies developed after Sinovac's (SVA) COVID-19 vaccine declined below a key threshold after six months of second dose, although a third shot had a strong booster effect, Reuters reports. Among participants who received two doses, t...
SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it received a drug registration approval from the National Medical Product Administration of China (“NMPA...
borchee/iStock via Getty Images COVID-19 Lambda variant that was first identified in Peru in August 2020 has surged in prevalence in the country, accounting for 97% of all detected cases by April 2021. According to World Health Organization ((WHO)), the Lambda variant has now been found ...
Sinovac Biotech (SVA) has signed an advance purchase agreement ((APA)) with Gavi, the Vaccine Alliance, to provide up to 380M doses of inactivated COVID-19 vaccine, CoronaVac for distribution through the COVAX Facility. According to the APA, Sinovac will supply 50M doses of CoronaVac by ...
SINOVAC Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it had signed an advance purchase agreement (APA) with Gavi, the Vaccine Alliance (Gavi), which is on behalf of CO...
Rodrigo Paiva/Getty Images News Some Asian countries that relied on the COVID-19 vaccine from Sinovac Biotech ([[SVA]]) are considering the administration of booster shots amid concerns over its efficacy as the prevalence of coronavirus Delta variant rises across the globe. After vaccinating ...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – May 1, 2024, Sernova Corp. (“Sernova” or the “Corporation”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) a clinical-stage biotechnology company focused on the development of regenerativ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The annual r...
--News Direct-- Dr. Philip Toleikis to retire as of April 30, 2024 Cost savings from restructuring and strategic transformation anticipated to extend runway Board rebuild underway LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - April 25, 2024 –...